Desktop Site |
04 Apr 25 | 16:00 | Close
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
BSE SENSEX 75,364.69 -930.67 -1.22 %
Corporate Announcement
  • Security Code532296
    CompanyGlenmark Pharmaceuticals Ltd
    Exchange Received Time20/03/2025 20:41:24
    Exchange Disseminated Time20/03/2025 20:41:24
    Time Taken00:00:00
     
     
     Announcement under Regulation 30 (LODR)-Press Release / Media Release | 3/20/2025 8:41:24 PM 
     Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(11H) 05 Apr 25|03:38 (IST)